AbstractWe demonstrate that the angiotensin-converting enzyme inhibitors enalapril and captopril inhibit the transport of D-Phe-L-Gln into PepT1-expressing Xenopus oocytes and into rat renal cortical brush border membrane vesicles (BBMV). The kinetics of inhibition are competitive. Enalapril and captopril are not substrates for PepT2 (Boll et al., Proc. Natl. Acad. Sci. 93 (1996) 284–289). Therefore we conclude that in rat renal cortical BBMV this neutral dipeptide is transported via PepT1
The peptide transporters PEPT1 and PEPT2 have become increasingly recognized over the past ten years...
In order to elucidate the mechanism and structural requirement for transport via the intestinal pept...
Given the nutritional, clinical, and pharmacological relevance of mammalian proton-coupled oligopept...
Peptide transporters participate in the absorption of peptidomimetic drugs from the intestine and th...
Peptide transporters participate in the absorption of peptidomimetic drugs from the intestine and th...
This dissertation examines the interaction between angiotensin converting enzyme (ACE) inhibitors an...
This dissertation examines the interaction between angiotensin converting enzyme (ACE) inhibitors an...
Recognition of ACE well as in reabsorbing filtered peptides generated by luminal Inhibitors in Xenop...
Purpose . To examine the mechanism of inhibition of glycylsarcosine(GlySar) transport by quinapril a...
To examine the inhibitory potential of enalapril and other ACE inhibitors on glycylsarcosine transpo...
Purpose . To examine the inhibitory potential of enalapril [and other angiotensin converting enzyme ...
ABSTRACT Angiotensin converting enzyme (ACE) inhibitors are important therapeutic agents for treatin...
Angiotensin-converting enzyme (ACE) inhibitors are often re-garded as substrates for the H/peptide t...
The peptide transporters PEPT1 and PEPT2 have become increasingly recognized over the past ten years...
In order to elucidate the mechanism and structural requirement for transport via the intestinal pept...
The peptide transporters PEPT1 and PEPT2 have become increasingly recognized over the past ten years...
In order to elucidate the mechanism and structural requirement for transport via the intestinal pept...
Given the nutritional, clinical, and pharmacological relevance of mammalian proton-coupled oligopept...
Peptide transporters participate in the absorption of peptidomimetic drugs from the intestine and th...
Peptide transporters participate in the absorption of peptidomimetic drugs from the intestine and th...
This dissertation examines the interaction between angiotensin converting enzyme (ACE) inhibitors an...
This dissertation examines the interaction between angiotensin converting enzyme (ACE) inhibitors an...
Recognition of ACE well as in reabsorbing filtered peptides generated by luminal Inhibitors in Xenop...
Purpose . To examine the mechanism of inhibition of glycylsarcosine(GlySar) transport by quinapril a...
To examine the inhibitory potential of enalapril and other ACE inhibitors on glycylsarcosine transpo...
Purpose . To examine the inhibitory potential of enalapril [and other angiotensin converting enzyme ...
ABSTRACT Angiotensin converting enzyme (ACE) inhibitors are important therapeutic agents for treatin...
Angiotensin-converting enzyme (ACE) inhibitors are often re-garded as substrates for the H/peptide t...
The peptide transporters PEPT1 and PEPT2 have become increasingly recognized over the past ten years...
In order to elucidate the mechanism and structural requirement for transport via the intestinal pept...
The peptide transporters PEPT1 and PEPT2 have become increasingly recognized over the past ten years...
In order to elucidate the mechanism and structural requirement for transport via the intestinal pept...
Given the nutritional, clinical, and pharmacological relevance of mammalian proton-coupled oligopept...